Skip to content
ASCIENDE

The Asciende advantage

Free Mexico shipping from $2,500 MXN

Shipping details

GnRH agonist peptide analog

Nafarelin

Nafarelin is a synthetic GnRH analog. Its studies distinguish peptide identity, preparation composition and metabolite tracking. Nafarelin acetate specifies a salt form but does not describe a complete formulation.

This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.

Hormonal axis, time and response type

Record time and model as well as name. A class label alone does not predict every response of a feedback system.

  • Is the entity described as an agonist, antagonist or modulator in the cited assay?
  • Are immediate response and adaptation after a different exposure distinguished?
  • Is the biomarker a direct receptor readout or a consequence of the whole axis?

Mechanism described in the literature

Nafarelin is classified as a GnRH agonist. Exposure research examines how much material reaches circulation and how it is transformed; these variables differ from receptor response.

Other names in the literature

  • Nafarelin

Composition modifies observed exposure

A 1988 pharmacokinetic study compared nafarelin preparations. Changes in nasal formulation composition were associated with absorption differences. The finding concerns those preparations rather than a fixed property of every solution containing the peptide.

A label also tracks transformation products

That work used labeled material to examine elimination and metabolites, identifying peptide fragments and non-peptide products. Detecting a label therefore does not necessarily detect intact nafarelin; the method must distinguish which chemical species generates the signal.

Comparisons with multiple outcomes

A 1994 randomized trial compared nafarelin acetate and buserelin acetate formulations. Several reproductive outcomes showed no significant difference, although a concomitant resource differed. Similarity in selected outcomes does not demonstrate molecular or pharmacokinetic equivalence.

Questions and answers

Does a marker signal always identify intact peptide?

No. Metabolites can retain the label; the nafarelin study separated these questions.

Does nafarelin acetate describe every excipient?

No. It identifies the ingredient's salt form; full composition requires additional preparation information.

Sources

  1. Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone. — Clin Pharmacol Ther, 1988
  2. Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.
  3. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer. — Hum Reprod, 1994
  4. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer.
Ayuda